Giant-Cell Tumor of Tendon Sheath clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

    open to eligible people ages 18 years and up

    A study to evaluate the long-term risk of hepatic failure with TURALIO™ (pexidartinib) and the mechanism of liver injury based upon optional liver biopsy information among patients who received or are receiving TURALIO™ (pexidartinib) and experience hepatotoxicity.

    Santa Monica 5393212, California 5332921 and other locations

Last updated: